Literature DB >> 27417993

Bowel perforation from occult ileal involvement after diagnosis in a case of primary mediastinal large B-cell lymphoma.

Chiara De Philippis1, Maria Chiara Di Chio1, Elena Sabattini2, Niccolo Bolli1.   

Abstract

Primary mediastinal large B-cell lymphoma (PMBCL) is confined to the mediastinum or contiguous nodal areas in most cases. Extramediastinal and abdominal involvement, especially at diagnosis, is extremely rare. Our case describes the first case of histologically proven ileal involvement of PMBCL at diagnosis that led to ileal perforation. Positron emission tomography CT could increase the sensitivity of staging by detecting unusual sites of disease localisation, and could impact clinical management. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Year:  2016        PMID： 27417993      PMCID： PMC4956975          DOI： 10.1136/bcr-2016-216317

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  11 in total

Review 1.  Primary mediastinal B-cell lymphoma: a review of pathology and management.

Authors:  K van Besien; M Kelta; P Bahaguna
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

2.  Gastric involvement in patients with primary mediastinal large B-cell lymphoma.

Authors:  Sotirios G Papageorgiou; Sotirios Sachanas; Gerassimos A Pangalis; Olga Tsopra; Georgia Levidou; Periklis Foukas; Phoivi Rondogianni; Vasileios Sotiropoulos; Helen-Dikaia Ioannidou; Argyris Gassiamis; Theodoros Iliakis; Penelope Korkolopoulou; Maria K Angelopoulou; Vasiliki Pappa; Konstantinos Konstantopoulos; Theodoros P Vassilakopoulos
Journal:  Anticancer Res       Date:  2014-11       Impact factor: 2.480

Review 3.  Primary mediastinal large B-cell lymphoma.

Authors:  Vijaya Raj Bhatt; Rajesh Mourya; Runa Shrestha; James O Armitage
Journal:  Cancer Treat Rev       Date:  2015-04-21       Impact factor: 12.111

4.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

Review 5.  CNS involvement in primary mediastinal large B-cell lymphoma.

Authors:  P C Bishop; W H Wilson; D Pearson; J Janik; E S Jaffe; P C Elwood
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

6.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors:  Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

7.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

Review 8.  Primary mediastinal large B-cell lymphoma.

Authors:  Maurizio Martelli; Andrés J M Ferreri; Peter Johnson
Journal:  Crit Rev Oncol Hematol       Date:  2008-09-07       Impact factor: 6.312

9.  Non-Hodgkin's lymphomas, version 4.2014.

Authors:  Andrew D Zelenetz; Leo I Gordon; William G Wierda; Jeremy S Abramson; Ranjana H Advani; C Babis Andreadis; Nancy Bartlett; John C Byrd; Myron S Czuczman; Luis E Fayad; Richard I Fisher; Martha J Glenn; Nancy Lee Harris; Richard T Hoppe; Steven M Horwitz; Christopher R Kelsey; Youn H Kim; Susan Krivacic; Ann S LaCasce; Auayporn Nademanee; Pierluigi Porcu; Oliver Press; Rachel Rabinovitch; Nishitha Reddy; Erin Reid; Ayman A Saad; Lubomir Sokol; Lode J Swinnen; Christina Tsien; Julie M Vose; Joachim Yahalom; Nadeem Zafar; Mary Dwyer; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2014-09       Impact factor: 11.908

10.  Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

Authors:  Kieron Dunleavy; Stefania Pittaluga; Lauren S Maeda; Ranjana Advani; Clara C Chen; Julie Hessler; Seth M Steinberg; Cliona Grant; George Wright; Gaurav Varma; Louis M Staudt; Elaine S Jaffe; Wyndham H Wilson
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.